Effectiveness of the Mediterranean Diet on Weight Loss After Endoscopic Bariatric Treatmen

Mediterranean-style and Open Protein Diet Plans on Weight Loss in Patients With Obesity After Endoscopic Bariatric Treatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04738656

Enrollment

Registered

2021-02-04

Start date

2015-07-01

Completion date

2019-01-01

Last updated

2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Obesity, Morbid

Keywords

Endoscopic bariatric treatment, Excess weight loss, Excess body mass index, Mediterranean diet plan, Open protein diet plan

Brief summary

All participants were weighed every week for 24 weeks, wearing light clothes to the nearest 0.1 kg, using a body composition analyzer. Height was determined during the first clinic evaluation using a fixed wall stadiometer to the nearest 0.1 cm, in standing position. Intervention: Participants followed a liquid diet plan during the first week after the endoscopic bariatric procedure (Bioenterics Intragastric Balloon - BIB - or Primary Obesity Surgery Endoluminal - POSE -). Subsequently, subjects were randomly assigned either a Mediterranean-style or a protein diet plan. Energy intake was calculated according to the Spanish Consensus on Bariatric Endoscopy. The hypothesis of this project is to analyze whether the Mediterranean-style diet is more effective compared with the open protein diet plans in weight loss and weight relapse in subjects with obesity who underwent endoscopic bariatric therapies.

Interventions

DIETARY_SUPPLEMENTDiet plan

Mediterranean style is a non-restricted diet plan compared with the open protein diet plan

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* no previous gastric intervention * no hiatus hernias * not being pregnant or in breastfeeding * not having cardiac problems, and having regular values in coagulation and blood count, * having a positive psychological evaluation.

Exclusion criteria

* lack of compliance with the dietary treatment * adverse effects of the surgery * refuse to complete the treatment * lack of adherence

Design outcomes

Primary

Measure	Time frame
Weekly weight loss	Every week up to 24 weeks
Weight relapse after 36 weeks	1 time after 36 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026